Viewing Study NCT00330369


Ignite Creation Date: 2025-12-24 @ 10:57 PM
Ignite Modification Date: 2026-06-02 @ 7:28 PM
Study NCT ID: NCT00330369
Status: COMPLETED
Last Update Posted: 2014-03-18
First Post: 2006-05-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: DORADO - Fixed Doses of Darusentan as Compared to Placebo in Resistant Hypertension
Sponsor: Gilead Sciences
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hypertension View
Keywords: